Eko Analysis Software vs Imbio RV/LV Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Eko Health
VS
by Imbio

AI Verdict

Eko Analysis Software focuses on real-time auscultation and ECG analysis for early detection of heart murmurs and atrial fibrillation, integrating with digital stethoscopes for point-of-care or remote monitoring. In contrast, Imbio RV/LV Software analyzes CTPA scans to automatically measure ventricular diameters and calculate RV/LV ratios, primarily aiding in risk stratification for pulmonary conditions within a radiology workflow. While both are FDA-cleared AI tools in cardiology, they address different clinical problems using distinct data inputs and deployment models.

Choose Eko Analysis Software if…

Choose Eko Analysis Software if you require an FDA-cleared, AI-powered solution for real-time cardiac screening and monitoring at the point of care or during telehealth consultations. This tool is ideal for clinicians needing immediate assistance in detecting heart murmurs and atrial fibrillation through digital auscultation and ECGs, with the added benefit of secure cloud storage for patient recordings.

View Eko Analysis Software →

Choose Imbio RV/LV Software if…

Choose Imbio RV/LV Software if your workflow involves analyzing CTPA scans to assess right and left ventricular function for risk stratification, particularly in cases of suspected pulmonary embolism. This AI-driven solution automates precise ventricular diameter measurements and RV/LV ratio calculations, seamlessly integrating with existing PACS to provide critical insights without manual intervention.

View Imbio RV/LV Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Analysis Software Imbio RV/LV Software
Deployment Unknown Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27]
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Imbio RV/LV Software

Tool B, Imbio RV/LV Software, offers a fully automated workflow that requires no user intervention after scan completion and integrates seamlessly with standard reading environments like PACS. This automation significantly streamlines the radiologist's workflow. While Tool A, Eko Analysis Software, provides a user-friendly mobile app experience, Tool B's deep integration and hands-off operation within a radiology setting give it an edge in usability for its target users.

Clinical Value

Tie

Both tools offer significant and FDA-cleared clinical value in their respective domains. Tool A, Eko Analysis Software, aids in the early detection of cardiovascular diseases like heart murmurs and AFib at the point of care. Tool B, Imbio RV/LV Software, provides automated measurements for risk stratification in pulmonary conditions such as pulmonary embolism from CTPA scans. Both address critical clinical needs with validated AI, making it difficult to declare one superior in overall clinical impact.

Pricing & Value

Eko Analysis Software

Tool A, Eko Analysis Software, offers a freemium model where basic app features are free, with subscriptions required for full AI capabilities and advanced features. This transparent and flexible pricing model provides a low barrier to entry and allows users to experience the product before committing. Tool B, Imbio RV/LV Software, uses a subscription-based model tied to the number of analyses or installations, which is less transparent upfront and lacks a free entry point.

Enterprise Readiness

Imbio RV/LV Software

Tool B, Imbio RV/LV Software, demonstrates superior enterprise readiness with its diverse deployment options, including cloud, on-premise, and integration via numerous partner platforms (e.g., Nuance, Aidoc, Siemens Syngo.via). It also features DICOM compliant input/output and PACS integration, crucial for radiology workflows. While Tool A is cloud-based and HIPAA compliant, Tool B's extensive integration ecosystem and deployment flexibility make it more adaptable to complex enterprise IT environments.

Innovation

Eko Analysis Software

Tool A, Eko Analysis Software, shows greater innovation by integrating AI-powered diagnostics directly with a wearable digital stethoscope and mobile app for point-of-care use. This approach democratizes advanced cardiac screening and brings sophisticated analysis to the clinician-patient interaction. While Tool B's automation of imaging measurements is valuable, Tool A's fusion of a physical device with AI for real-time, accessible insights represents a more novel application in healthcare delivery.

Support & Docs

Tie

Both tools offer robust support and documentation resources. Eko provides a comprehensive Help Center with user manuals, how-to videos, and FAQs for its devices and app, alongside dedicated enterprise support for its SENSORA product. Imbio offers a structured support system with contact forms, phone numbers, and detailed user manuals for its software, outlining technical requirements and outputs. Both demonstrate a strong commitment to assisting their respective user bases through multiple channels and comprehensive documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Analysis Software Imbio RV/LV Software
Primary Clinical Use Assists clinicians in early detection of cardiovascular diseases like heart murmurs and atrial fibrillation. Automatically measures right and left ventricular diameters from CTPA scans to aid in risk stratification for pulmonary conditions like pulmonary embolism.
Target Medical Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Pulmonology, Radiology
Core AI Detections/Measurements FDA-cleared AI for heart murmur detection, FDA-cleared AI for atrial fibrillation (AFib) detection, detection of normal sinus rhythm, calculation of cardiac time intervals (heart rate, QRS duration). Automated measurement of right and left ventricular diameters, calculation and reporting of RV/LV ratio.
Input Data Source Digital stethoscopes (wireless auscultation), ECGs. CTPA scans (DICOM compliant input).
Output Formats Recording, playback, and annotation of heart sounds and ECGs; visualization of phonocardiograms (PCG) and ECG tracings; secure cloud-based storage; PDF reports. Annotated images showing ventricular measurements; summary PDF reports; DICOM compliant output; integration with standard reading environments (PACS).

Videos

Demos, reviews, and walkthroughs featuring Eko Analysis Software and Imbio RV/LV Software.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Analysis Software assists clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation, utilizing data from Eko's digital stethoscopes and mobile app, which capture heart sounds and ECGs. Imbio RV/LV Software, on the other hand, automatically measures right and left ventricular diameters from CTPA scans to aid in risk stratification for pulmonary conditions such as pulmonary embolism.
Eko Analysis Software integrates with Eko's digital stethoscopes and mobile app, offering a direct interface at the point of care, with secure cloud-based storage of recordings. Imbio RV/LV Software is DICOM compliant and integrates with standard reading environments like PACS, offering deployment options including cloud-based (AWS), on-premise (VMware solution), or via partner platforms such as Nuance, Aidoc, and Siemens Syngo.via.
Eko Analysis Software provides FDA-cleared AI for heart murmur detection, atrial fibrillation (AFib) detection, and normal sinus rhythm detection, along with calculating cardiac time intervals like heart rate and QRS duration. Imbio RV/LV Software offers automated measurement of right and left ventricular diameters and calculates the RV/LV ratio, providing annotated images and summary PDF reports.
Eko Analysis Software is designed for Cardiology, Emergency Medicine, and Internal Medicine specialties. Imbio RV/LV Software primarily supports Cardiology, Pulmonology, and Radiology.
Yes, both Eko Analysis Software and Imbio RV/LV Software are HIPAA compliant and have Business Associate Agreements (BAAs). Eko stores all data securely in the cloud within the United States and uses 256-bit AES encryption, while Imbio is third-party HIPAA compliant certified by Compliancy Group.

Backers

Who funded each tool's parent company.

Eko Analysis Software

AI Tool Finder
AI-powered search. Results may not be comprehensive.